Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02208466 · ClinicalTrials.gov registry record · Phase 2
Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients
A Phase 2 study, sponsored by Spaulding Rehabilitation Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT02208466 is a Phase 2 study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 44 participants.
The verdict
NCT02208466, a Phase 2 study, has completed, sponsored by Spaulding Rehabilitation Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
In this study investigator's aim to assess the effect of a type of non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) in conjunction with fluoxetine on motor recovery after stroke.
Interventions
- DRUG Fluoxetine
- DEVICE Active Repetitive Transcranial Magnetic Stimulation (rTMS)
- DEVICE Sham repetitive transcranial magnetic stimulation (rTMS)
- DRUG Placebo Fluoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2014-09 |
| Est. Completion | 2019-06-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02208466
The ClinicalTrials.gov registry entry for NCT02208466 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Fluoxetine is the first listed.
NCT02208466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02208466 about?
NCT02208466 is a clinical study titled "Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients". In this study investigator's aim to assess the effect of a type of non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) in conjunction with fluoxetine on motor recovery after stroke.
What is the current status of trial NCT02208466?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2014-09. Estimated completion is 2019-06-25.
What interventions are being tested in trial NCT02208466?
The interventions under investigation include: Fluoxetine (DRUG), Active Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE), Sham repetitive transcranial magnetic stimulation (rTMS) (DEVICE), Placebo Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT02208466?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.